Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gynecology
»
Breast Diseases
26. October 2026
Search
medline.ch
Breast Diseases
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Reproduction
Genital Diseases female
Infertility
Breast Diseases
Menopause
Pregnancy
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 11171
Articles 1 - 20 / 223407
Copper complexes in the triple-negative breast cancer landscape: advances and opportunities.
Front Mol Biosci
Lima PMAP, de Matos ACP, Guimarães GDS, Barbosa LAS, Araújo TG.
PMID: 42928858 [PubMed]
A Retrospective Study Analysing the Outcomes of Anxiety, Depression, and Sleep Disorders in Post-Chemotherapy Patients With Breast Cancer Based on Symptom-Targeted Supportive Psychological Nursing.
Actas Esp Psiquiatr
Shi Y, Zhou Y, Yan J, Zhao R, Zhang Q, Xu J.
PMID: 42928681 [PubMed - indexed for MEDLINE]
Contextual diagnostic framework for evaluating histopathology grey zones: a proposal with medicolegal implications using breast pathology as a model.
Virchows Arch
Rakha EA, Shaaban AM, Van Bockstal MR, Decker T, Foschini MP, Badve S, Abuhejleh MA, Altrabulsi B, Pinder SE, Tan PH, Quinn C, Ellis IO.
PMID: 42928370 [PubMed - as supplied by publisher]
Use of hair relaxers and hair dyes during pregnancy and breast tissue composition in mothers and adolescent daughters.
Breast Cancer Res
Chan M, Lilge L, Walter J, Tehranifar P, Miller RL, Hoang A, Shephard P, Perera F, Herbstman JB, Terry MB, McDonald JA, Kehm RD.
PMID: 42928199 [PubMed - indexed for MEDLINE]
A novel Hemoglobin-Albumin-Lymphocyte-Platelet (HALP)-based prognostic model to predict the progression of premenopausal breast cancer: a retrospective cohort study.
BMC Cancer
Zhang S, Xu L, Peng W.
PMID: 42928141 [PubMed - indexed for MEDLINE]
Molecular mechanisms and targeted therapeutic strategies of TIGAR in regulating energy metabolism to promote tumor proliferation in breast cancer.
Breast Cancer
Zhai M, Wang P, Ou Y.
PMID: 42927599 [PubMed - as supplied by publisher]
A large-scale consensus study of a diagnostic algorithm for canine and feline mammary tumor histopathology: An attempt to improve inter-observer agreement.
Vet Pathol
Cocumelli C, Crescio MI, Abbate JM, Abbondati E, Monsef YA, Andrews E, Antuofermo E, Bacci B, Baldassarre V, Bauer K, Belluco S, Bergmann W, Brachelente C, Brambilla E, Brunetti B, Burrai GP, Caliskan N, Canadas-Sousa A, Cloup E, Coutermarsh-Ott S, Culang D, Cvetko M, d'Aquino I, Darie L, De Biase D, De Paolis L, Degiovanni C, Uberti BD, Di Teodoro G, Dimatteo M, Eleni C, Fonti N, Galietta V, Gama A, Gasparini S, Geerinckx L, Giacomazzo M, Giambrone G, Giglia G, Godizzi F, Goldschmidt M, Gomba, Gouveia BA, Grest P, Grieco V, Gunnes G, Haugland S, He C, Heier A, Herrmann A, Hill-Thimmesch K, Hirabayashi M, Inan S, Selina I, Kagawa Y, Kalpers S, López-Cabré E, Machado AT, Mainenti M, Maniscalco L, Manuali E, Millanta F, Miller M, Moccia V, Montemurro V, Negoescu A, Nguyen F, Orioles M, Orlandi M, Paciello O, Parisi F, Peña L, Plog S, Polinas M, Porcellato I, Psalla D, Puget C, Puleio R, Raso C, Rasotto R, Rezaee Oghazi M, Riccardi E, Rodrigues-Jesus J, Romanucci M, Ruiz-Riera E, Sfacteria A, Soto S, Spr, Taulescu M, Tekavec Kmetec K, Turchetto S, Valdivia G, Valente S, Wiener D, Yoshimura H, Zappulli V.
PMID: 42927477 [PubMed - as supplied by publisher]
Development and Validation of a Lipid Metabolism-Related Gene Prognostic Model for Breast Cancer: Integrating Risk Score and Nomogram.
Breast Care (Basel)
Yin Y, Yan J, Wang J, Yuan M.
PMID: 42927407 [PubMed - as supplied by publisher]
Timing of cranial radiotherapy in HER2-positive breast Cancer brain metastases treated with Pyrotinib: a multicentre real-world cohort study.
Clin Transl Radiat Oncol
Chen Z, Jing H, Huang S, Wang M, Mao D, Li L, Lu S, Zhou X, Bi D, Zhang Y, Chen X, Ma Y, Xia Y, Yi J, Hou Y.
PMID: 42927325 [PubMed]
A HALF CENTURY OF PROGRESS IN BREAST CANCER: WHERE DO WE GO NEXT?
Trans Am Clin Climatol Assoc
Winer EP.
PMID: 42927318 [PubMed - indexed for MEDLINE]
Baseline prevalence of lung cancer screening and associated factors among women in breast cancer screening clinics prior to the Pink & Pearl program: A retrospective analysis of electronic health records.
Res Sq
Odeny B, Ramaswamy SG, Bowe B, Zewde E, Mnatzakanian A, Akinloye B, Odeny T, Lee MV.
PMID: 42926932 [PubMed]
Thrombotic Risk of Targeted Therapies in Breast Cancer: A Real-World Cohort Study.
Res Sq
Boland W, Guzik G, Grinsztejn E, Perez JA, Plevniak K, Bannow BS, Nayak L, Martin J.
PMID: 42926660 [PubMed]
Menopause timing, hormone therapy, epigenetic aging, and breast cancer outcomes: a secondary analysis of the PLCO Cancer Screening Trial.
medRxiv
Zhai T, Pankratz VS, Zychowski KE, Li Y, Leslie KK, Guo Y, Amos CI, Cook LS, Leng S.
PMID: 42926595 [PubMed]
Explainable WinDWS-SwinNet: Optimizing Ultrasound Deep Radiomics for Multipathology Breast Lesion Classification.
Acad Radiol
Sharma D, Chauhan S.
PMID: 42926176 [PubMed - as supplied by publisher]
Pembrolizumab Plus Chemotherapy for HR+/HER2- PD-L1‒Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study.
Ann Oncol
Rugo HS, Kok M, Goncalves A, Loirat D, Bianchini G, Fasching PA, Cescon DW, Díaz RR, Zagouri F, Korbenfeld E, Dalenc F, Gilarranz YJ, Hashimoto J, Park YH, Im SA, Hu X, Hirshfield KM, Jia L, Tryfonidis K, Schmid P.
PMID: 42926111 [PubMed - as supplied by publisher]
Atirmociclib and fulvestrant for patients with HR+/HER2- advanced/metastatic breast cancer who progressed on a prior cyclin-dependent kinase 4/6 inhibitor: primary analysis of the randomized FourLight-1 trial.
Ann Oncol
Giordano A, Xu B, Yoshinami T, Huang CS, Park YH, Lerzo GL, Li H, Shai A, Jaliffe GG, Itoh M, Williams A, Goel S, Im SA, Cobb P, Golmakani M, Liu F, Moss RA, Vana A, Ignatiadis M, Rugo HS.
PMID: 42926110 [PubMed - as supplied by publisher]
Overall survival from the phase III postMONARCH trial of abemaciclib plus fulvestrant versus placebo plus fulvestrant for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy.
Ann Oncol
Kalinsky K, Wander SA, Hamilton E, Graff SL, Jeselsohn R, Park KH, Demirci U, Martin M, Layman RM, Hurvitz SA, Sammons S, Kaufman PA, Ravenberg E, Amdur S, Litchfield LM, Bianchini G.
PMID: 42926108 [PubMed - as supplied by publisher]
Comparative assessment of skin toxicity in prone vs supine positions during postoperative breast radiotherapy: A systematic review and meta-analysis.
Cancer Treat Res Commun
Sawaira F, Khalid AA, Qazi H, Kukreja S, Yasir M, Hayat S, Waqas M, Junaid M, Shahab SH, Gul O, Mughees M, Sajid MS, Farooq U, Ur Rehman M, Arsalan M.
PMID: 42925844 [PubMed - as supplied by publisher]
DIEP versus SIEA flap in autologous breast reconstruction: A systematic review and meta-analysis.
J Plast Reconstr Aesthet Surg
Morelli Coppola M, Brunetti B, Mureddu CP, Scarabosio A, Jaber GJ, di Summa PG, Tenna S, Persichetti P.
PMID: 42925712 [PubMed - as supplied by publisher]
Efficacy of an AIMP1-Derived Peptide (NeoPep-S) for Radiation-Induced Dermatitis in Breast Cancer Patients: A Prospective Randomized Active-Controlled Trial.
Aesthetic Plast Surg
Kim MJ, Kim HG, Han HM, Lim HS, Park YJ, Lee IJ.
PMID: 42925326 [PubMed - as supplied by publisher]
Articles 1 - 20 / 223407
Page 1 of 11171
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy